Medicine prescribes and hopes. We let it see.
Bardel turns the body's response to any treatment into objective, real-time insight. For the first time, clinicians can know whether a therapy is actually working, between visits, not just whether it was taken.
For 40 years, the most important question in medicine has been answered with a guess.
Pain has been measured by a 0-to-10 question since the 1980s. Roughly 76 million patients are treated every year with no data on whether the treatment worked. Medicine cannot see the response, so it escalates, switches, and hopes.
The body is already reporting how it is responding. No one was listening.
Every intervention produces a physiological signature in how the body responds. That signature is the constant. The drug, the dose, the disease, the device, all of it is configuration. Read the response, and you can read whether any treatment is working.
The phenotype is the constant. Everything else is configuration.
One platform. Any intervention. A complete picture of how the body is responding.
Trak+ is the intelligence layer that captures the physiological signal others miss, from a phone camera, a watch, a chest strap, or a clinical monitor, and turns it into an objective treatment-response read.
Capture
Any intervention, from devices patients and hospitals already have.
Measure
The body's response, in real time.
Match
The right treatment to the response, dose by dose.
Bill
Turn monitoring into reimbursable revenue from day one.
Learn
Every session compounds into a dataset that gets smarter.
Built for everyone who needs to know if a treatment is working.
The same platform. Configured for your world.
Patients
Your recovery is a journey, not a number.
Hospitals
A software layer on the monitors you already own.
Clinicians
New revenue on day one. Objective data for every dose.
Payers
Stop paying for therapy that is not working.
Pharma
The real-world evidence dataset that does not exist anywhere else.
Government & VA
An objective measurement standard for those who served.
This is already real.
Not a concept. A platform with live devices, peer-reviewed foundations, and patients who keep coming back. As of 2026.
Our advisors bring more than 200 years of combined experience to the table.
They led the U.S. Ozempic launch at Novo Nordisk, ran a roughly $23 billion Medicare P&L at Aetna, served as VP, Global Commercial at Johnson & Johnson and as VP, Healthcare Investment Banking at Wells Fargo, hold a PhD from Cornell behind the discovery of the Spexin peptide, founded Princeton Pain Management, and have led multibillion-dollar pharma exits.
Validated by decades of peer-reviewed cardiac research.
Bardel did not invent the signal. We built the platform that finally captures it in real time, for any treatment. The science is settled. The infrastructure was missing.
Clinicians, operators, and engineers who have done this before.
Led by a founder, a CTO out of AWS and Capital One, a CFA-credentialed CFO, and a Harvard- and Stanford-trained Chief Biomedical Officer, advised by people who have built and scaled in this category.
Lars Zeepvat
Founder & CEO
Frederick Sion
Co-Founder & CTO
Dr. Karyemaitre Aliffe
Chief Biomedical Officer
Cameron Downing
Chief Marketing Officer
Dr. Brian Shaffer
Clinical Pain Advisor
Medicine has been flying blind. It does not have to anymore.
See the platform, or explore a partnership.